Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Chubb
McKinsey
Boehringer Ingelheim
Federal Trade Commission
Moodys
Cerilliant
Queensland Health

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,040,344

« Back to Dashboard

Summary for Patent: 6,040,344
Title: Formoterol process
Abstract:A method is disclosed for the preparation of optically pure isomers of formoterol by the reaction of an optically pure 4-benzyloxy-3-formamidostyrene oxide with an optically pure 4-methoxy-.alpha.-methyl-N-(phenylmethyl)benzeneethanamine followed by debenzylation. Useful intermediates in the process are also disclosed, as are the novel L-tartrate salt of R,R-formoterol and pharmaceutical compositions thereof.
Inventor(s): Gao; Yun (Southborough, MA), Hett; Robert (Aarau, CH), Fang; Kevin Q. (Wellesley, MA), Wald; Stephen A. (Sudbury, MA), Redmon; Martin P. (Marlborough, MA), Senanayake; Chris Hugh (Shrewsbury, MA)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:09/083,010
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,040,344
Patent Claim Types:
see list of patent claims
Compound; Composition; Delivery; Dosage form;

Drugs Protected by US Patent 6,040,344

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,040,344

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 219047 ➤ Try a Free Trial
Austria 259779 ➤ Try a Free Trial
Australia 2705900 ➤ Try a Free Trial
Australia 5175598 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Harvard Business School
Express Scripts
AstraZeneca
Healthtrust
Citi
Colorcon
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.